| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| 3-(4-hydroxy-phenyl)-2,3-diphenyl-acrylonitrile | protein kinase c alpha | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 3-(4-hydroxy-phenyl)-2,3-diphenyl-acrylonitrile | protein kinase c beta | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 3-(4-hydroxy-phenyl)-2,3-diphenyl-acrylonitrile | protein kinase c delta | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 3-(4-hydroxy-phenyl)-2,3-diphenyl-acrylonitrile | protein kinase c epsilon | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 3-(4-hydroxy-phenyl)-2,3-diphenyl-acrylonitrile | protein kinase c gamma | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 3-(4-hydroxy-phenyl)-2,3-diphenyl-acrylonitrile | protein kinase c theta | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 3-(4-hydroxy-phenyl)-2,3-diphenyl-acrylonitrile | protein kinase c zeta | NA | Patented-recorded target | TTD | NA | NA | investigative | unknown |
| click here to return to the previous page | ||||||||